Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Washington University School of Medicine
Institut Bergonié
Intensity Therapeutics, Inc.
Eisai Inc.
Incyte Corporation
Wake Forest University Health Sciences
Institut Bergonié
Novartis
Incyte Corporation
Amgen
UNC Lineberger Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Barbara Ann Karmanos Cancer Institute
Altor BioScience